01 1Wanbury Limited
01 1DIPHENHYDRAMINE CITRATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-07-13
Pay. Date : 2021-06-15
DMF Number : 19986
Submission : 2006-11-15
Status : Active
Type : II
20
Wanbury Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DIPHENHYDRAMINE CITRATE, with a corresponding US DMF Number 19986.
Remarkably, this DMF maintains an Active status since its submission on November 15, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 13, 2021, and payment made on June 15, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
